Human placental lactogen
Human placental lactogen (hPL), also known as human chorionic somatomammotropin (HCS), is a hormone produced by the placenta during pregnancy. It plays a crucial role in regulating the metabolic state of the mother to support the growing fetus.
Structure and Function
Human placental lactogen is a polypeptide hormone, structurally similar to human growth hormone (hGH) and prolactin (PRL). It is produced by the syncytiotrophoblast cells of the placenta and is released into the maternal circulation.
The primary function of hPL is to modify the metabolic state of the mother during pregnancy. It increases the availability of glucose and amino acids for the fetus by promoting lipolysis and inhibiting glucose uptake in maternal tissues. This hormone also stimulates the production of insulin and insulin-like growth factor in the mother, leading to increased insulin resistance and higher blood glucose levels.
Role in Pregnancy
Human placental lactogen plays a significant role in fetal development and maternal adaptation to pregnancy. It promotes the growth of the mammary glands in preparation for lactation and has a luteotropic effect, maintaining the function of the corpus luteum and the production of progesterone, which is essential for the maintenance of pregnancy.
In addition, hPL may have immunomodulatory effects, contributing to the maternal immune tolerance of the fetus.
Clinical Significance
Abnormal levels of hPL can indicate complications in pregnancy. Low levels may suggest placental insufficiency, while high levels can be associated with conditions such as gestational diabetes and placental overgrowth disorders like placental chorioangioma and hydatidiform mole.
Prenatal diagnosis of these conditions can be achieved through the measurement of hPL levels in maternal serum or urine.
See Also
References

This article is a endocrinology stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
